Ayman Yosry

Ombitasvir, paritaprevir, and ritonavir plus ribavirin for chronic hepatitis C virus genotype 4 infection in Egyptian patients with or without compensated cirrhosis (AGATE-II): a multicentre, phase 3, partly randomised open-label trial

Imam Waked, Gamal Shiha, Roula Qaqish et al. · ˜The œLancet. Gastroenterology & hepatology · 2016 · 73 citations

Open-label Trial, Hepatology, Hepatitis C +9

Planning and prioritizing direct-acting antivirals treatment for HCV patients in countries with limited resources: Lessons from the Egyptian experience

Aisha Elsharkawy, Maissa El Raziky, Wafaa Elakel et al. · Journal of Hepatology · 2017 · 73 citations

Hcv Patients, Direct-acting Antivirals Treatment, Egyptian Experience +10

Transluminal retroperitoneal endoscopic necrosectomy with the use of hydrogen peroxide and without external irrigation: a novel approach for the treatment of walled-off pancreatic necrosis

Mohamed Sayed Abdelhafez, Mayada Elnegouly, Maha S Hasab Allah et al. · Surgical Endoscopy · 2013 · 63 citations

External Irrigation, Walled-off Pancreatic Necrosis, Pancreatic Fluid Collection +7

Real life Egyptian experience of efficacy and safety of Simeprevir/Sofosbuvir therapy in 6211 chronic <scp>HCV</scp> genotype <scp>IV</scp> infected patients

Rasha Eletreby, Wafaa Elakel, Mohamed Said et al. · Liver International · 2016 · 60 citations

Circulatory miRNA-484, 524, 615 and 628 expression profiling in HCV mediated HCC among Egyptian patients; implications for diagnosis and staging of hepatic cirrhosis and fibrosis

Shohda A. El‐Maraghy, Ola Adel, Naglaa Zayed et al. · Journal of Advanced Research · 2019 · 45 citations · Full text